Research programme: nitrone-related therapeutics - RenovisAlternative Names: Nitrone-Related Therapeutics research programme; NRT
Latest Information Update: 01 May 2007
At a glance
- Originator AstraZeneca; Renovis
- Mechanism of Action Free radical scavengers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alzheimer's disease; Eye disorders; Multiple sclerosis; Myocardial infarction
Most Recent Events
- 06 Jan 2000 Preclinical development for Multiple sclerosis in USA (PO)
- 06 Jan 2000 Preclinical development for Eye disorders in USA (PO)
- 06 Jan 2000 Preclinical development for Myocardial infarction in USA (PO)